Winston Pharmaceuticals, Inc.
WPHM · OTC
12/31/2009 | 12/31/2008 | 9/30/2007 | 9/30/2006 | |
|---|---|---|---|---|
| Market Cap | $5,513 | $4,808 | $148 | $55 |
| - Cash | $1,563 | $5,627 | $4,482 | $0 |
| + Debt | $0 | $0 | $0 | $251 |
| Enterprise Value | $3,950 | -$819 | -$4,333 | $306 |
| Revenue | $1,395 | $453 | $0 | $0 |
| % Growth | 208.2% | – | – | – |
| Gross Profit | $1,386 | $444 | $0 | -$209 |
| % Margin | 99.4% | 98.1% | – | – |
| EBITDA | -$2,732 | -$5,226 | -$200 | -$418 |
| % Margin | -195.9% | -1,154.7% | – | – |
| Net Income | -$2,655 | -$5,142 | -$180 | -$465 |
| % Margin | -190.4% | -1,136.2% | – | – |
| EPS Diluted | -0.04 | -0.1 | -0.08 | -0.8 |
| % Growth | 60% | -25% | 90% | – |
| Operating Cash Flow | -$4,199 | -$3,062 | -$173 | -$106 |
| Capital Expenditures | -$1 | -$16 | $0 | $0 |
| Free Cash Flow | -$4,200 | -$3,079 | -$173 | -$106 |